Monterey Bay Labs

Epidermal Delivery Platform Using Natural Micro-injectors

Health Tech & Life Sciences
Non Active, Dec 2017 ceased to operate
Follow

Company Overview

Snapshot

Founded in August 2000, Monterey Bay Labs has 11–50 employees and was co-founded by Mark Uicker. The company has raised $9,000,000 across one funding round. In February 2014, the company, then known as StarletDerma, signed a collaboration deal with L'Oreal.

Business overview

Monterey Bay Labs, formerly StarletDerma, is a delivery platform company specializing in dermatology and skincare. The company develops its proprietary InoCyte system, which utilizes natural, marine-extracted technology to deliver drugs through micro-injectors, similar to those used by sea anemones. This technology is supported by a broad IP portfolio covering marine biology, mass cultivation, formulations, and production methods for active topical delivery. Monterey Bay Labs operates in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Cosmetic Materials, serving the healthcare, life sciences, cosmetics, and pharmaceutical industries.

Strategic signal

In February 2014, Monterey Bay Labs, operating as StarletDerma, secured a collaboration deal with L'Oreal. This partnership provided significant strategic validation for its InoCyte epidermal delivery platform, demonstrating its potential for commercial application within the cosmetics and dermatology markets and signaling strong industry interest in its innovative drug delivery technology.

Log in to access full profile

Company Intelligence Q&A

What is the primary technology developed by Monterey Bay Labs?
Monterey Bay Labs develops the InoCyte system, an epidermal delivery platform that uses natural, marine-extracted micro-injectors for drug delivery in dermatology and skincare applications.
When was Monterey Bay Labs founded and by whom?
Monterey Bay Labs was founded in August 2000, with Mark Uicker as a co-founder.
What significant collaboration did the company secure in 2014?
In February 2014, Monterey Bay Labs, then known as StarletDerma, signed a collaboration deal with L'Oreal for its epidermal delivery platform.
What is the total capital raised by Monterey Bay Labs?
Monterey Bay Labs has raised a total of $9,000,000 across one funding round.
Where are Monterey Bay Labs' operations located?
Monterey Bay Labs has an office in Palo Alto, CA, USA, and its fully owned R&D subsidiary, Monterey Bay Labs Ltd (Israel), is located in Caesarea Industrial Park, Israel.
Log in to access full profile